Cargando…
Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?
AIM: To assess whether serum thymidine kinase 1 (STK1p), CEA and CA19.9 can be used as prognostic biomarkers in the primary tumor location (PTL) of colorectal carcinoma (CRC). Additional clinical factors of TNM stage, pathological grade, age and sex were also included. METHODS: STK1p was determined...
Autores principales: | Fang, Yujing, Skog, Sven, Ou, Qingjian, Chen, Zhiheng, Liu, Senbo, Hei, Ailian, Li, Jin, Zhou, Ji, He, Ellen, Wan, Desen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938097/ https://www.ncbi.nlm.nih.gov/pubmed/36800051 http://dx.doi.org/10.1007/s12672-023-00614-5 |
Ejemplares similares
-
A meta-analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment
por: Dang, Li, et al.
Publicado: (2020) -
Serum thymidine kinase 1 protein concentration for predicting early progression and monitoring the response to TACE in hepatocellular carcinomas: a network meta-analysis
por: Ma, Hongbo, et al.
Publicado: (2021) -
Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery
por: Wang, Xiangbin, et al.
Publicado: (2023) -
Investigation on Cell Proliferation with a New Antibody against Thymidine Kinase 1
por: Wang, Naining, et al.
Publicado: (2001) -
Serum CNPY2 isoform 2 represents a novel biomarker for early detection of colorectal cancer
por: Peng, Jianhong, et al.
Publicado: (2018)